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BACKGROUND: Peripherally inserted central catheters
(PICCs) are commonly inserted during hospitalization for a
variety of clinical indications.
OBJECTIVE: To understand hospitalist experience, prac-
tice, knowledge, and opinions as they relate to PICCs.
DESIGN AND SETTING: Web-based survey of hospitalists
in 5 healthcare systems (representing a total of 10 hospitals)
across Michigan.
RESULTS: The overall response rate was 63% (227 hospi-
talists received invitations; 144 responded). Compared with
central venous catheters, hospitalists felt that PICCs were
safer to insert (81%) and preferred by patients (74%).
Although 84% of respondents reported that placing a PICC
solely to obtain venous access was appropriate, 47% also
indicated that 10%–25% of PICCs inserted in their hospitals
might represent inappropriate placement. Hospitalist knowl-
edge regarding PICC-related venous thromboembolism
was poor, with only 4% recognizing that PICC-tip verifica-
tion was performed principally to prevent thrombosis. Fur-
thermore, several potential practice-related concerns were
identified: one-third of hospitalists indicated that they never
examine PICCs for externally evident problems, such as
exit-site infection; 48% responded that once inserted, they
did not remove PICCs until a patient was ready for dis-
charge; and 51% admitted that, at least once, they had
“forgotten” that their patient had a PICC.
CONCLUSIONS: Hospitalist experiences, practice, opin-
ions, and knowledge related to PICCs appear to be vari-
able. Because PICC use is growing and is often associated
with complications, examining the impact of such variation
is necessary. Hospitals and health systems should consider
developing and implementing mechanisms to monitor PICC
use and adverse events. Journal of Hospital Medicine
2013;8:309–314.VC 2013 Society of Hospital Medicine.
Peripherally inserted central catheters (PICCs) have
become among the most common central venous cath-
eters (CVCs) used in contemporary medical practice.1
Although they were originally developed for delivery
of parenteral nutrition, the use of PICCs has expanded
to include chemotherapy administration, long-term in-
travenous (IV) antibiotic treatment, and venous access
when obtaining peripheral veins is difficult (eg,
occluded peripheral veins, unusual venous anato-
mies).2 Despite these roles, little is known about PICC
use in hospitalized patients. This knowledge gap is im-
portant, as PICCs are placed in inpatient settings for a
variety of reasons. Some of these reasons may not be
appropriate, and inappropriate PICC use may worsen
outcomes and increase healthcare costs.3 In addition,
PICCs are not innocuous and are frequently associated
with important complications including thrombophle-
bitis, central-line–associated bloodstream infection
and venous thromboembolism.4–6 Therefore, under-
standing patterns and knowledge associated with
PICC use is also an important patient safety concern.
As the main providers of inpatient care, hospitalists
frequently order the insertion of PICCs and treat
PICC-related complications. Unfortunately, to date,
no study has surveyed hospitalists regarding manage-
ment or use of PICCs. Understanding hospitalist expe-
riences, practice, opinions, and knowledge related to
PICCs is therefore of significant interest when examin-
ing present-day PICC use. To bridge this important
knowledge gap and better understand these practices,
we conducted a Web-based survey of hospitalists in 5
healthcare systems in the state of Michigan.
METHODS
A convenience sample of hospitalists (N5227) was
assembled from 5 large healthcare systems (represent-
ing 10 hospitals) that participate in the Hospital Med-
icine Safety (HMS) Consortium, a Blue Cross/Blue
Shield of Michigan–funded statewide collaborative
quality initiative. Individuals engaged in research,
quality improvement, or leadership at HMS sites were
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invited to serve as site principal investigators (site
PIs). Site PIs were responsible for obtaining regulatory
approval at their parent facilities and disseminating
the survey to providers in their group. Participation in
the survey was solicited via e-mail invitations from
site PIs to hospitalists within their provider group. To
encourage participation, a $10 electronic gift card was
offered to respondents who successfully completed the
survey. Reminder e-mails were also sent each week by
site PIs to augment participation. To enhance study
recruitment, all responses were collected anony-
mously. The survey was administered between August
2012 and September 2012; data collection occurred
for 5 weeks during this interval.
Survey questions were derived from our published,
evidence-based conceptual framework of PICC-related
complications. Briefly, this model identifies complica-
tions related to PICCs as arising from domains related
to patient-, provider-, and device-related characteristics
based on existing evidence.2 For our survey, questions
were sourced from each of these domains so as to
improve understanding of hospitalist experience, prac-
tice, opinions, and knowledge regarding PICC use. To
ensure clarity of the survey questions, all questions were
first pilot-tested with a group of randomly selected hos-
pitalist respondents at the University of Michigan
Health System. Direct feedback obtained from these
respondents was then used to iteratively improve each
question. In order to generate holistic responses, ques-
tions were designed to generate a response reflective of
the participants “typical” PICC use/scenario. We used
SurveyMonkey to collect and manage survey data.
Statistical Analyses
Variation in hospitalist experience, reported practice,
opinions, and knowledge regarding PICCs was assessed
by hospitalist type (full time vs part time), years of
practice (<1, 1–5, >5), and care-delivery model (direct
care vs learner-based care). Bivariate comparisons were
made using the v2 or Fisher exact tests as appropriate;
2-sided a with a P value <0.05 was considered statisti-
cally significant. All analyses were conducted using
Stata version 11 (StataCorp, College Station, TX).
Local institutional review board approval was obtained
at each site participating in the survey.
RESULTS
A total of 227 surveys were administered and 144
responses collected, for a survey response rate of
63%. Each participating site had unique characteris-
tics including size, number of hospitalists, and modal-
ity of PICC insertion (Table 1). Of the hospitalists who
completed the survey, 81% held full-time clinical posi-
tions and had been in practice an average of 5.6 years.
Surveyed hospitalists reported caring for an average of
40.6 patients per week and ordering a mean of 2.9
(range, 0–15) PICCs per week of clinical service. Among
survey respondents, 36% provided direct patient care,
34% provided care either directly or through mid-level
providers and housestaff, and 9% delivered care exclu-
sively through mid-level providers or housestaff (Table
2). As our survey was conducted anonymously, poten-
tial identifying information such as age, race, and sex of
those responding was not collected.
Hospitalist Experiences and Practice Related to
Peripherally Inserted Central Catheters
According to responding hospitalists, the most com-
mon indications for PICC placement were long-term
IV antibiotic treatment (64%), followed by inability
to obtain peripheral venous access (24%). Hospitalists
reported an average duration of PICC placement of
17 days (range, 3–42 days). A significant percentage
of hospitalists (93%) stated that they had cared for
patients where a PICC was placed only for use during
hospitalization, with the most common reason for
such insertion being difficulty in otherwise securing
venous access (67%). Respondents also reported car-
ing for patients who had both PICCs and peripheral
IV catheters in place at the same time; 49% stated
that they had experienced this <5 times, whereas
33% stated they had experienced this 5–10 times. Fur-
thermore, 87% of respondents indicated having
admitted a patient who specifically requested a PICC
due to prior difficulties with venous access. More than
half of surveyed hospitalists (63%) admitted to having
been contacted by a PICC nurse enquiring as to
whether their patient might benefit from PICC
insertion.
The majority of hospitalists (66%) reported that
they specified the number of lumens when ordering
TABLE 1. Characteristics of Participating Sites
Survey Site
No. of
Hospitals
No. of
Inpatient Beds
No. of Annual
Inpatient Encounters
No. of
Hospitalists
Full-Time
Hospitalists, %
Avg. No. Weeks/
Year on Service
Avg. Years
of Experience
No. PICCs/
Week, 2012
Modality of PICC
Insertion Available
University of Michigan
Health System
1 9001 5,775 46 100 25 6 42 Vascular access nurse
Ann Arbor VA Medical Center 1 135 825 16 50 17.6 5.1 12 Vascular access nurse
Spectrum Health System 2 800 14,000 47 80 34 3.75 56 Interventional radiology
Trinity Health System 3 634 2,300 67 80 24 4 31 Interventional radiology
and hospitalists
Henry Ford Health System 3 1,150 1,450 51 100 20.4 5.6 15 Vascular access nurse
NOTE: Abbreviations: Avg., average; PICC, peripherally inserted central catheter; VA, Veterans Affairs.
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PICCs. Thirty-eight percent indicated that this deci-
sion was based on type of medication, whereas 35%
selected the lowest number of lumens possible. A
power PICC (specialized PICCs that are designed to
withstand high-pressure contrast injections), was spe-
cifically requested for radiographic studies (56%),
infusion of large volume of fluids (10%), or was the
default PICC type at their facility (34%).
A majority (74%) of survey respondents also
reported that once inserted, PICCs were always used
to obtain blood for routine laboratory testing. More-
over, 41% indicated that PICCs were also always
used to obtain blood for microbiological cultures. The
3 most frequently encountered PICC-related complica-
tions reported by hospitalists in our survey were
blockage of a PICC lumen, bloodstream infection, and
venous thromboembolism (VTE; Table 3).
Hospitalist Opinions Regarding Peripherally
Inserted Central Catheters
Compared with CVCs, 69% of hospitalists felt that
PICCs were safer and more efficient because they
could stay in place longer and were less likely to cause
infection. Most (65%) also agreed that PICCs were
more convenient than CVCs because they were
inserted by PICC teams. Additionally, 74% of hospi-
talists felt that their patients preferred PICCs because
they minimize pain from routine peripheral IV
changes and phlebotomy. A majority of respondents
(84%) indicated that it was appropriate to place a
PICC if other forms of peripheral venous access could
not be obtained. However, when specifically ques-
tioned, 47% of hospitalists indicated that at least
10%–25% of PICCs placed in their hospitals might
represent inappropriate use. A majority (78%) agreed
with the statement that the increase in numbers of
vascular nurses had influenced use of PICCs in
TABLE 2. Descriptive Characteristics of Study
Population
Characteristic Total (N5144)
Hospitalist type, n (%)
Full time 117 (81)
Part time 19 (13)
Unknown 8 (6)
Weeks/year on a clinical service, n (%)
<20 24 (17)
20 107 (74)
Unknown 13 (9)
Mean (SD) 25.5 (10.7)
Median 26
Type of patients treated, n (%)
Adults only 129 (90)
Adults and children 7 (5)
Unknown 8 (6)
Years in practice as a hospitalist, n (%)
5 81 (56)
>5 54 (38)
Unknown 9 (6)
Model of care delivery, n (%)
Direct 52 (36)
Some midlevel or housestaff providers (<50% of all encounters) 49 (34)
Mostly midlevel or housestaff providers (>50% of all encounters) 22 (15)
Only midlevel or housestaff providers 13 (9)
Unknown 8 (6)
Location of practice
Trinity Health System 39 (27)
University of Michigan Health System 37 (26)
Henry Ford Health System 28 (19)
Spectrum Health System 21 (15)
Ann Arbor VA Medical Center 11 (8)
Unknown 8 (6)
NOTE: Abbreviations: SD, standard deviation; VA, Veterans Affairs.
TABLE 3. Key Hospitalist Experience and Opinions
Regarding PICCs
Hospitalist Experiences With PICCs Total (N5 144)
Primary indication for PICC placement*
Long-term IV antibiotics 64
Venous access in a patient with poor peripheral veins 24
Parenteral nutrition 5
Chemotherapy 4
Patient specifically requested a PICC 1
Unknown/other 2
PICC placed only for venous access, n (%)
Yes 135 (94)
No 9 (6)
PICC placed only during hospitalization, n (%)
Yes 134 (93)
No 10 (7)
Notified by a PICC nurse (or other provider) that patient may need or benefit from a PICC, n (%)
Yes 91 (63)
No 53 (37)
How frequently PICCs are used to obtain blood for routine laboratory testing, n (%)
Always 106 (74)
Unknown/other 38 (26)
How frequently PICCs are used to obtain blood for blood cultures, n (%)
Always 59 (41)
Unknown/other 85 (59)
Hospitalist Opinions on PICCs Total (N5 144)
In your opinion, is it appropriate to place a vascular in a hospitalized patient if other forms of periph-
eral access cannot be obtained? n (%)
Yes 121 (84)
No 21 (15)
Unknown 2 (1)
In your opinion, should hospitalists be trained to insert PICCs? n (%)
No 57 (40)
Yes, this is an important skill set for hospitalists 46 (32)
Unsure 39 (27)
Unknown/other 2 (1)
Do you think the increasing number of vascular nurses and PICC nursing teams has influenced the
use of PICCs in hospitalized patients? n (%)
Yes 112 (78)
No 30 (21)
Unknown 2 (1)
What % of PICC insertions do you think may represent inappropriate use in your hospital? n (%)
<10 53 (37)
10–25 68 (47)
25–50 18 (13)
>50 3 (2)
Unknown/other 2 (1)
NOTE: Abbreviations: IV, intravenous; PICC, peripherally inserted central catheter.
*Mean response values are reflected.
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hospitalized patients, but most (45%) were neutral
when asked if PICCs were more cost-effective than
traditional CVCs.
Hospitalist Knowledge Regarding Risk of
Peripherally Inserted Central Catheter–Related
Venous Thromboembolism and Bloodstream
Infection
Although 65% of responding hospitalists disagreed
with the statement that PICCs were less likely to lead
to VTE, important knowledge gaps regarding PICCs
and VTE were identified (Table 4). For instance, only
4% of hospitalists were correctly aware that the
PICC-tip position is checked to reduce risk of PICC-
related VTE, and only 12% knew that the site of
PICC insertion has also been associated with VTE
risk. Although 85% of respondents stated they would
prescribe a therapeutic dose of an anticoagulant in the
case of PICC-associated VTE, deviations from the
guideline-recommended 3-month treatment period
were noted. For example, 6% of hospitalists reported
treating with anticoagulation for 6 months, and 19%
stated they would treat as long as the PICC remained
in place, plus an additional period of time (eg, 2–4
weeks) after removal. With respect to bloodstream
infection, 92% of responding hospitalists correctly
identified PICC duration and prompt removal as fac-
tors promoting PICC-related bloodstream infection
and 78% accurately identified components of the
catheter-associated bloodstream infection bundle.
When specifically asked about factors associated with
risk of PICC-related bloodstream infection, only half
of respondents recognized the number of PICC lumens
as being associated with this outcome.
Variation in Hospitalist Knowledge, Experience,
or Opinions
We assessed whether any of our findings varied
according to hospitalist type (full time versus part
time), years of practice (<1, 1–5, >5), and model of
care delivery (direct care vs learner-based care). Our
analyses suggested that part-time hospitalists were
more likely to select “rarely” when it came to finding
patients with a PICC and a working peripheral IV at
the same time (74% vs 45%, P5 0.02). Interestingly,
a higher percentage of those in practice <5 years indi-
cated that 10%–25% of PICCs represented inappro-
priate placement (58% vs 33%, P< 0.01) and that
vascular nurses had influenced the use of PICCs in
hospitalized patients (88% vs 69%, P5 0.01). Lastly,
a higher percentage of hospitalists who provided
direct patient care reported that PICCs were always
used to obtain blood for microbiological culture (54%
vs 37%, P5 0.05).
DISCUSSION
In this survey of hospitalists practicing at 5 large
healthcare systems in Michigan, we observed signifi-
cant variation in experience, reported practice, opin-
ions, and knowledge related to PICCs. Our findings
highlight important concerns related to inpatient
PICC use and suggest a need for greater scrutiny
related to these devices in these settings.
The use of PICCs in hospitalized patients has risen
dramatically over the past decade. Though such
growth is multifactorial and relates in part to increas-
ing inpatient volume and complexity, hospitalists have
increasingly turned to PICCs as a convenient and
reliable tool to obtain venous access.7 Indeed, in our
survey, PICCs that were only used during hospitaliza-
tion were most likely to be placed for this very reason.
Because PICCs are safer to insert than CVCs and the
original evidence regarding PICC-related VTE or
bloodstream infection suggested low rates of these
events,8–14 many hospitalists may not perceive these
TABLE 4. Key Knowledge Gaps and Variation
Regarding PICC-Related VTE
Total (N5144)
Why is the position of the PICC tip checked after bedside PICC insertion? n (%)
To decrease the risk of arrhythmia related to right-atrial positioning 108 (75)
To minimize the risk of VTE* 6 (4)
To ensure it is not accidentally placed into an artery 16 (11)
For documentation purposes (to reduce the risk of lawsuits related
to line-insertion complications)
6 (4)
Unsure/Unknown 8 (6)
According to the 2012 ACCP Guidelines on VTE prevention, is pharmacologic prophylaxis for DVT
recommended in patients who receive long-term PICCs? n (%)
No; no anticoagulant prophylaxis is recommended for patients
who receive long-term PICCs*
107 (74)
Yes, but the choice and duration of anticoagulant is at the discretion
of the provider
23 (16)
Yes; aspirin is recommended for 3 months 4 (3)
Yes; anticoagulation with warfarin or enoxaparin is recommended for 3 months 3 (2)
Yes; anticoagulation with warfarin or enoxaparin is recommended for 6 months 2 (1)
Unknown 5 (4)
Assuming no contraindications exist, do you anticoagulate patients who develop a PICC-associated
DVT (with any therapeutic anticoagulant)? n (%)
Yes* 122 (85)
No 16 (11)
Unknown 6 (4)
How long do you usually prescribe anticoagulation for patients who develop PICC-associated
DVT? n (%)
I don’t prescribe anticoagulation 12 (8)
1 month 4 (3)
3 months* 84 (58)
6 months 8 (6)
As long as the line remains in place; I stop anticoagulation
once the PICC comes out
3 (2)
As long as the line remains in place and for an additional specified
period of time after line removal, such as 2 or 4 weeks
27 (19)
Unknown 6 (4)
As part of the treatment of PICC-related DVT, do you routinely remove the PICC?† n (%)
Yes 102 (71)
No 36 (25)
Unknown 6 (4)
NOTE: Abbreviations: ACCP, American College of Chest Physicians; DVT, deep venous thrombosis; PICC,
peripherally inserted central catheter; VTE, venous thromboembolism.
*Correct answer.
†This represents an unresolved issue; thus, there is no correct guideline recommended answer.
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devices as being associated with significant risks. In
fact, some have suggested that hospitalists be specifi-
cally trained to insert these devices, given their safety
compared with traditional CVCs.7
However, accumulating evidence suggests that PICCs
are associated with important complications.5,15,16 In
studies examining risk of bloodstream infection, PICCs
were associated with significant risk of this out-
come.6,17,18 Recently, the presence of a PICC was iden-
tified as an independent predictor of VTE in
hospitalized patients.19 Several studies and systematic
reviews have repeatedly demonstrated these findings.19–
22 A recent systematic review examining nonpharmaco-
logic methods to prevent catheter-related thrombosis
specifically called for avoidance of PICC insertion to
prevent thrombosis in hospitalized patients.23 Despite
this growing evidence base, the use of PICCs in the
inpatient setting is likely to rise, and our survey high-
lights several practices that may contribute to adverse
outcomes. For instance, hospitalists in our survey were
unlikely to remove a PICC until a patient was dis-
charged, irrespective of the need for this device. As
each day with a PICC increases the risk of complica-
tions, such practice poses potential patient safety con-
cerns. Similarly, many hospitalists believe that PICCs
are safer than CVCs, a viewpoint that does not stand
up to increasing scrutiny and highlights important
knowledge gaps. The risk of PICC-related complica-
tions appears not to be a stationary target, but rather a
dynamic balance that is influenced by patient-, pro-
vider-, and device-specific characteristics.2 Increasing
discretionary use (especially for patients with poor pe-
ripheral venous access), forgetting at times that a
patient has a PICC, and the finding that up to 25% of
PICCs placed in their hospitals may be unnecessary
underscore concerns regarding the safety of current
practice trends. Interestingly, the viewpoints of hospi-
talists in practice <5 years and those providing direct
patient care were more likely to reflect concerns regard-
ing inappropriate placement, influence of vascular
nurses, and use of PICCs for blood culture. This find-
ing may reflect that these nuances are more recent phe-
nomena or perhaps most apparent when care is
delivered directly.
Our study must be interpreted in the context of sev-
eral limitations. First, as this was a survey-based study
of a small, convenience sample of hospitalists in a sin-
gle state, recall, respondent, and systematic biases
remain threats to our findings. However, all site PIs
encouraged survey participation and (through local
dialogue) none were aware of material differences
between those who did or did not participate in the
study. Similarly, Michigan is a diverse and relatively
large state, and our results should be generalizable to
other settings; however, national studies are necessary
to confirm our findings. Second, our response rate
may be perceived as low; however, our rates are in ac-
cordance with, and, in fact, superior to those of many
existing physician surveys.24 Finally, only 1 federal fa-
cility was included in this study; thus, this care-deliv-
ery model is underrepresented, limiting generalization
of findings to other such sites.
However, our study also has important strengths.
First, this is the only survey that specifically examines
hospitalist viewpoints when it comes to PICCs. As hos-
pitalists frequently order and/or insert these devices,
their perspectives are highly pertinent to discussions
regarding current PICC use. Second, our survey high-
lights several instances that may be associated with pre-
ventable patient harm and identifies areas where
interventions may be valuable. For example, forgetting
the presence of a device, keeping PICCs in place
throughout hospitalization, and rendering treatment for
PICC-related VTE not in accordance with accepted
guidelines are remediable practices that may lead to
poor outcomes. Interventions such as device-reminder
alerts, provider education regarding complications from
PICCs, and systematic efforts to identify and remove
unnecessary PICCs may mitigate these problems.
Finally, our findings highlight the need for data reposi-
tories that track PICC use and hospitalist practice on a
national scale. Given the risk and significance of the
complications associated with these devices, under-
standing the epidemiology, use, and potential misuse of
PICCs are important areas for hospitalist research.
In conclusion, our study of hospitalist experience,
practice, opinions, and knowledge related to PICCs
suggests important gaps between available evidence
and current practice. There is growing need for the
development of appropriateness criteria to guide vas-
cular access in inpatient settings.25,26 Such criteria
should consider not only type of venous access device,
but granular details including rationale for venous
access, nature of the infusate, optimal number of
lumens, and safest gauge when recommending devices.
Until such criteria and comparative studies become
available, hospitals should consider instituting policies
to monitor PICC use with specific attention to indica-
tion for insertion, duration of placement, and compli-
cations. These interventions represent a first and
necessary step in improving patient safety when it
comes to preventing PICC-related complications.
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